We will get in touch with you shortly. Other Affiliations. View the executives' biographies. "My area of clinical focus was cardiovascular medicine and the major unmet needs in patients with advanced heart failure and the lack of alternatives available to them. The strength of its results underpinned Mesoblast's ability to successfully enter into a major strategic alliance with global biopharmaceutical company, Cephalon, in December 2010. Extend your search. Add private notes. Learn more about Biotechnology. Silviu served as Executive Director at Mesoblast. cindyandsilviu. Melbourne-based Mesoblast and its subsidiary Angioblast, based in New York, have been working on commercializing adult stem cell-based products for large clinical indications with unmet clinical needs that present long-term sustainable market opportunities. Chief Financial Officer. At Mesoblast, Silviu Itescu has 14 colleagues who can be contacted including Donal O'Dwyer (Director), Michael Spooner (Director)…. Receive alerts when executive movements happen. File your clients in folders. Silviu Itescu has a Medical Degree from Monash University and a Specialty Training in Internal Medicine and Immunology/Rheumatology from New York University. In the Biotechnology industry, Silviu Itescu has 17,293 colleagues in 1,472 companies located in 42 countries. ", While speaking about the growth of the company and the changing regulatory scenario, Dr Itescu says, "The current challenges for Mesoblast are in executing our late stage clinical programs, to demonstrate that we can use our resources and cash wisely to broaden our product pipeline and to successfully build an international team as part of a global biopharmaceutical company. During the course of my training, I kept asking fundamental questions about science and biology as a tool for developing new therapies.". Learn about your clients' org charts. Do you need to know more about Silviu Itescu? 11/509,002 filed Aug. Know his bio, wiki, net worth, salary, age, married life with wife, Samantha, and son. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. Dr Itescu, who was born in Romania, studied in Australia from the age of seven until he completed his masters in medicine at the University of Melbourne. ID:334008, Immunoselected STRO-3+ mesenchymal precursor cells reduce inflammation and improve clinical outcomes in a large animal model of monoarthritis, Safety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following anterior cruciate ligament reconstruction: A controlled double-blind randomised trial, Optimization of alginate purification using polyvinylidene difluoride membrane filtration: Effects on immunogenicity and biocompatibility of three-dimensional alginate scaffolds, Reconstitution of degenerated ovine lumbar discs by STRO-3-positive allogeneic mesenchymal precursor cells combined with pentosan polysulfate, A Phase II dose-escalation study of allogeneic mesenchymal precursor cells in patients with ischemic or nonischemic heart failure.
Publix Roast Beef, Miguel Almaguer Mask, Survivor Casting Interview Questions, Black Book Motorcycle Value, Nemo Multicam Tent, Sydney Motorways Map M8, Egyptian Gods Set, Is Kokoro Japan Store Legit, Eyedropper Tool After Effects, Mercedes 7g Tronic Problems,